Skip to content
Friday 28 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,792.54
-0.79%
DAX
26,367.24
+0.31%
CAC 40
8,319.87
0.00%
STOXX 50
6,424.73
-0.71%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 15 March 2017 7:18 pm

Oxford University on a high as Star Trek star backs medicinal cannabis research

By: Imran Khan

Add as a preferred source on Google

Star Trek actor Sir Patrick Stewart has publicly endorsed cannabis research at Oxford University, after admitting to using the drug for medicinal reasons in America.

Stewart has backed the UK’s first ever research project launched by Oxford University today which aims to explore the benefits of cannabinoid-based medicines for sufferers of arthritis like himself.

Stewart said he uses cannabis sprays, rubs his hands in ointment and swallows pills, all loaded with the substance.

The research, funded by private equity firm Kingsley Capital Partners, will be carried out by Oxford Cannabinoid Technologies, a new company set up to partner with academics from the university.

Stewart said: "I purchased an ointment, spray and edibles. The ointment, while providing some relief from the discomfort, was too greasy to use during daytime and so I only use it at night. It helps with sleep as the pain was reduced.

"I believe that the ointment and spray have significantly reduced the stiffness and pain in my hands. I can make fists, which was not the case before I began this treatment.

“The spray, however, is much more usable and I spray my fingers and particularly my thumb joints several times a day,” he added.

Neil Mahapatra of Kingsley Capital Partners said the partnership with Oxford would “support the development of innovative new therapies to help millions of people around the world”.

It comes after a report published by a cross-party group of MPs and peers called on the government to allow sick people to grow their own cannabis under licence.

The all-party parliamentary group for drug policy reform also wants companies to be allowed to import or grow the drug, and for ministers to strip away legal controls so that medicinal cannabis becomes less regulated than many painkillers.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money
  • News

Categories

  • Business
  • Investing
  • Money

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Andy Burnham hints at tax rises in Autumn Budget

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • Economists urge Bank of England to halt bond sales as borrowing costs climb

More from Morning Wire

  • Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma

    Business Wire
  • State pension set to pile pain on next generation of taxpayers, Healey warned

    Politics
    Andy Burnham and Angela Rayner interacting with children at an outdoor event
  • Why did Pinterest choose Oxford Street for its new HQ?

    Opinion
    Gregory Owens and Sadiq Khan, London Mayor, stand smiling in a gallery with various framed images.
  • Nscale doubles London office space as UK staff grows sixfold

    AI
    2024 was a transformational year for GlobalData.
  • TOURISE and Oxford Economics Release New Global Report on Tourism Resilience in an Era of Permanent Disruption

    Business Wire
  • It’s not just Jason Arday, most of sociology is a scam

    Opinion
    Jason Arday smiling, wearing academic regalia with a blue cap and gown with red accents.
  • Organigram Reports Record Third Quarter Fiscal 2026 Results

    Business Wire
  • COSMOS, Intel, and Airspan to Test and Evaluate OCUDU in End-to-End, 5G/NextG Deployment Scenarios

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook